Embedded Files
Veterans Affairs Medical Center, Birmingham, Alabama; 15Benjamin J. Smith, DMSc, PA-C: Florida State University College of Medicine School of Physician Assistant Practice, Tallahassee; 16Jeffrey A. Sparks, MD, MMSc, Michael E. Weinblatt, MD: Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts; 17Shilpa Venkatachalam, PhD: Global Healthy Living Foundation, Upper Nyack, New York; 18Mounir AlGibbawi, MD, Fatimah Chamseddine, MD, Lara Kahale, RN, MSc, PhD, Basil S. Karam, MD, Assem M. Khamis, MD, MPH, Sally Yaacoub, RPh, MPH, Elie A. Akl, MD, MPH, PhD: American University of Beirut, Beirut, Lebanon; 19Joshua F. Baker, MD, MSCE: Corporal Michael J. Crescenz VA Medical Center and the University of Pennsylvania, Philadelphia, Pennsylvania; 20Kamil E. Barbour, PhD, MPH, MS: Centers for Disease Control and Prevention, Atlanta, Georgia; 21Jennifer L. Barton, MD, MCR, Pascale Schwab, MD: Oregon Health & Science University and VA Portland Health Care System, Portland, Oregon; 22Laura Cappelli, MD, MHS, MS: Johns Hopkins Medicine, Baltimore, Maryland; 23Michael George, MD, MSCE: University of Pennsylvania, Philadelphia; 24Sindhu R. Johnson, MD, PhD, FRCPC: Toronto Western Hospital, Mount Sinai Hospital, Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; 25Iris Navarro-Millán, MD, MSPH: Weill Cornell Medicine, New York, New York; 26Reza Mirza, MD: University of Toronto, Toronto, Ontario, Canada; 27Namrata Singh, MD, MSCI, FACP: University of Washington, Seattle; 28Marat Turgunbaev, MD, MPH, Amy S. Turner: American College of Rheumatology, Atlanta, Georgia. Dr. Bathon has received consulting fees, speaking fees, and/or honoraria from Gilead Biosciences (less than $10,000). Dr. St.Clair has received consulting fees, speaking fees, and/or honoraria from Bristol Myers Squibb (less than $10,000) and royalties from UpToDate. Dr. Deane has received consulting fees, speaking fees, and/or honoraria from Bristol Myers Squibb, Inova Diagnostics, Janssen, and Microdrop (less than $10,000 each). Dr. Genovese has received consulting fees, speaking fees, and/or honoraria from AbbVie, Amgen, BeiGene, Eli Lilly and Company, GlaxoSmithKline, Pfizer, Sanofi, R-Pharm, and SetPoint Medical (less than $10,000 each) and owns stock or stock options in Gilead Sciences. Dr. Huston has received consulting fees and/or honoraria from Trio Health Advisory (less than $10,000). Dr. Kerr has received consulting fees, speaking fees, and/or honoraria from Jansen, Sanofi, and Genzyme (less than $10,000 each). Dr. Kremer has received consulting fees, speaking fees, and/ or honoraria from AbbVie, Bristol Myers Squibb, Gilead, Eli Lilly and Company, and Pfizer (less than $10,000 each) and owns stock or stock options in Corrona. Dr. Singh has received consulting fees, speaking fees, and/or honoraria from MediSYS, Fidia Pharma, UBM, Trio Health, Medscape, WebMD, Clinical Care Options, Clearview Healthcare Partners, Putnam Associates, Focus Forward, Navigant Consulting, Spherix, Practice Point Communications (less than $10,000 each), and Simply Speaking (more than $10,000) and owns stock or stock options in Vaxart Pharmaceuticals. Dr. Weinblatt has received consulting fees, speaking fees, and/or honoraria from AbbVie, Amgen, Canfite, Crescendo, GlaxoSmithKline, Horizon, Johnson & Johnson, Genentech/Roche, Scipher, SetPoint, Tremeau (less than $10,000 each), Eli Lilly and Company, Bristol Myers Squibb, Gilead, and Corrona (more than $10,000 each), royalties from Elsevier, and owns stock or stock options in Canfite, Scipher, Inmedix, and Vorso. Dr. Baker has received consulting fees, speaking fees, and/or honoraria from Bristol Myers Squibb, Gilead, Burns-White, and Simply Speaking Rheumatology (less than
Report abuse